Background: Limited data are available regarding the association between glucose levels variability (GV) and outcomes of patients hospitalized with acute infectious diseases. Aim: To determine the association between GV and bacteremia, length of stay (LOS) and mortality. Methods: A retrospective study of patients hospitalized in departments of medicine with respiratory tract, urinary tract and skin and soft tissue infections during 2011-17. GV was assessed by the coefficient of variation (CV) of glucose levels during hospitalization and was divided into tertiles (CV 16%, 17-29%, >29%). LOS, bacteremia rates and all-cause mortality (30 days, 90 days and after 5 years) were evaluated for the patients with and without DM according the three GV categories Results: The study consisted of 1485 patients, 838 (56%) were diabetic. There was no significant association between GV and LOS. Bacteremia rates were higher in the upper GV tertile compared with the lower one (6% vs. 2%, P ¼ 0.007). Mid and upper tertiles compared with the lower one were significantly associated with increased 30-day mortality (13% vs. 5%, P ¼ 0.005; and 40% vs. 5%, P ¼ 0.002, respectively). A decreased 5 years survival was observed for both diabetic and non-diabetic patients in the mid and upper GV tertiles [adjusted HRs 0.8 (95% CI, 0.6-1.04) and 0.6 (95% CI, 0.5-0.9) in diabetic patients and 0.7 (95% CI, 0.5-0.9) and 0.5 (95% CI, 0.3-0.7) in the non-diabetic ones]. Conclusion: In diabetic and non-diabetic patients, hospitalized in non-ICU setting with acute infectious diseases, increased GV is associated with increased risk of bacteremia, short and long-term mortality.
Introduction
Diabetes mellitus (DM) leads to decline in immunity, resulting in increased risk for urinary tract infections (UTIs), respiratory tract infection (RTIs), skin and soft tissue infections (SSIs). [1] [2] [3] The high rate of infections among diabetic patients can be explained by immune function impairment, especially the innate one and neutrophil dysfunction; defects in adaptive immunity; as well as vascular damage that leads to poor tissue perfusion and neuropathy that results in unnoticed injuries and infections. [4] [5] [6] Poor glycemic control has a significant impact on infection related mortality. In a retrospective study on hospitalized patients with pneumonia, the mean plasma glucose level during hospitalization was higher among patients who died within 30 days compared to those who survived; this association remained significant after adjustment for the severity of pneumonia. 7 In another study on pneumococcal pneumonia patients, the admitting plasma glucose levels were higher in subjects who died within 30 days compared to the ones who survived. 8 Glycemic variability (GV) relates to blood glucose levels fluctuations that might differ among patients with similar mean glucose and hemoglobin A1C levels. 9 High GV is considered an indicator of poor glycemic control and increased risk for complications, including long hospital stay and mortality. In a retrospective study on patients admitted to medical wards, inhospital mortality was associated with higher GV in patients with and without DM. 10 Another study on patients admitted to surgical and medical wards showed that increased GV during hospitalization was independently associated with increased 90 days mortality. 11 The same was found among ICU critically ill patients, where increased GV was independently associated with higher mortality and increased infections rate. 12 Never the less, scarce data is available regarding patients hospitalized with acute infections in the departments of medicine. The aim of the study was to explore the association between GV during hospitalization and bacteremia rates, length of stay (LOS) and all-cause short and long term mortality among non-ICU setting patients hospitalized with common acute infections.
Materials and methods
A retrospective study, conducted at a tertiary medical center. The inclusion criteria included: patient >18 years old that were hospitalized in the medical service of Beilinson Hospital, Israel between January 2011 and December 2017; the main admission diagnosis was either RTI, UTI or SSI (See Supplementary Appendix S1 for CDC/NHSN Surveillance Definitions for specific types of infections); having at least three blood glucose level values during hospitalization. Blood glucose level was measured in venous blood obtained by vein puncture. We excluded patients who were admitted to any intensive care unit; patients with a diagnosis of Clostridium difficile infection, endovascular infection including infective endocarditis, diabetic foot, infected decubitus ulcer, osteomyelitis, necrotizing fasciitis, toxic shock syndrome, infection of prosthesis and or foreign body as well as ones with missing data. Patients who were presented with bacteremia at admission were also excluded from the study.
Data were extracted from the patients' electronic records, including: demographics [age, gender]; BMI; comorbidities, including: DM, hypertension, malignancy, ischemic heart disease, congestive heart failure, stroke and chronic renal failure; the discharge diagnosis of infectious disease; laboratory results, including: white blood cells and platelet count, creatinine, albumin and C reactive protein levels as well as venous blood glucose levels; hypoglycemic medications; blood culture results; LOS, and mortality at 30 days, 90 days and after 5 years (end of follow up).
DM was defined according to previous diagnosis of DM and or by using any chronic hypoglycemic treatment. The glucose targets levels were according the guidelines for non-ICU subjects, between 140 mg/dl and 180 mg/dl. 13 The dysglycemia treatment was planned individually by the treating physicians according the severity of infection and the level of dysglycemia. It was based on basal bolus insulin regimens or any modification of the patients' hypoglycemic treatment before hospitalization. The GV was defined by the coefficient of variation (CV). The CV was calculated as the ratio of standard deviation (SD) to mean glucose values, expressed as a percentage.
The GV of the entire cohort was stratified into tertiles: low tertile (CV 16%), medium (CV 17-29%) and upper one (CV > 29%).
The study outcomes, LOS, bacteremia rates, and all-cause mortality (30 days, 90 days and after 5 years (end of follow up period), were evaluated for the patients with and without DM according the three GV categories.
Statistical analysis
The statistical analysis was generated by using SAS Software, version 9.4 (SAS Institute).
The chi-square test was used for comparing dichotomous variables; continuous data were expressed as mean 6 SD or as median and interquartile range (25-75 percentiles) as appropriate and compared by the using Mann-Whitney rank sum test.
An interaction between DM and GV with each study outcome was calculated, elucidating whether GV had a different impact on patients with DM and patients without DM. In cases where no interaction between DM and GV was observed, the data was analysed as one cohort.
Overall survival was assessed by Kaplan-Meier survival analysis, with the log-rank test. The Cox proportional hazards model was used to assess overall survival adjusted for age, gender, BMI, hypertension, malignancy, ischemic heart disease, congestive heart failure, stroke, chronic renal failure and hypoglycemia. Two-sided P values, 0.05 were considered statistically significant.
Results
The eligible subjects group, hospitalized patients with acute infection hospitalized during the study period, included 2004 patients. After exclusion the ones with fewer than three glucose level measurements during hospitalization, the final study cohort consists of 1485 subjects, including 771 (52%) with RTI, 460 (31%) with UTI, and 256 (17%) with SSI. Of the entire cohort, 838 (56%) were diabetic and 647 (44%) were not.
Study cohort
The demographic and clinical characteristics of the study cohort according the diagnosis of DM are provided in Table 1 , the glycemic metrics according to diabetic status of the cohort are presented in Table 2 .
Patients with DM were older and with higher BMI (74 6 13 vs. 65 6 20 years, <0.001 and 28 6 8 vs. 26 6 6 kg/m 2 , P < 0.001, respectively). In addition, the diabetic patients were more likely to have SSI (24% vs. 9%, P < 0.001) and less likely to have RTI and UTI than the patients without DM (27% vs. 36%, P < 0.001 and 49% vs. 55%, P ¼ 0.03, respectively). Rates of hypertension, ischemic heart disease, congestive heart failure and stroke were considerably higher among the diabetic subjects. The median number of blood glucose level measurements was higher among the diabetic subjects (6 vs. 4, P < 0.001) with higher median GV (27% vs. 17%, P < 0.001). Of the diabetic patients, 256 (31%) were on insulin therapy and 563 (67%) on oral hypoglycemic medications, 19 (2%) were not treated (Data not shown).
Most of the diabetic patients were in the upper GV tertile (47%, 393), whereas most of the non-diabetic ones were in the lower one (47%, 307). The median glucose levels (mg/dl) during hospitalization according the GV tertiles were in the DM group: 154, 153, 165 and in the patients without DM, 105, 111 and 112, respectively.
Bacteremia
There was no statically significant interaction between DM, GV and bacteremia rates (data not shown). Therefore, the bacteremia rates were analysed as one cohort.
The rates of Bacteremia were higher in the upper GV tertile as compared with the lower one, 6% vs. 2%, P ¼ 0.007.
Length of stay
As there was also no statically significant interaction between DM, GV and LOS (data not shown), the data was analysed as one cohort.
The mean LOS (days) did not significantly differ between the GV tertiles (7 6 8 in the lower tertile, 8 6 27 in the middle one and 8 6 10 in the higher one).
Mortality

Short term mortality
As there was no statically significant interaction between DM, GV and 30-days or 90-days mortality (data not shown), the data was analysed as one cohort.
The 30 day mortality rates were significantly higher in the middle and higher tertiles compared with the lower one (13% vs. 5%, P ¼ 0.005; and 40% vs. 5%, P ¼ 0.002, respectively), whereas the 90-days mortality rates were significantly higher in the Table 3) .
Long term mortality
As there was a statically significant interaction between DM, GV categories and 5 years (end of follow up) mortality, the data was analysed separately for patients with and without DM. Overall 5 years mortality rate for the entire cohort was 42% (626/1485 patients), 46% of the diabetic patients (382/838) and 38% of the subjects without it (244/647). Higher GV tertiles were associated with increased long term mortality in both the diabetic and non-diabetic patients. In the diabetic group: middle vs. low GV tetrile: 45% vs. 36%, hazard ratio (HR) 0.8 (95% CI, 0.6-1.04); high vs. low GV tertiles: 51% vs. 36%, HR, 0.6 (95% CI, 0.5-0.9). Among the non-diabetic subjects: middle vs. lower GV tertiles: 41% vs. 28%, HR 0.6 (95% CI, 0.5-0.8); high vs. low GV tertiles: 60% vs. 28%, HR 0.3 (95% CI, 0.2-0.5). After adjustment for study variables, the respective adjusted HRs were 0.7 (95% CI, 0.5-1.1) and 0.7 (95% CI, 0.5-0.9) for the diabetic patients and 0.7 (95% CI, 0.5-0.9) and 0.5 (95% CI, 0.3-0.7) for the non-diabetic ones. (Table 4 and Figure 1 ).
Discussion
The study results show an increased risk of bacteremia as well as short and long term mortality rates among diabetic and nondiabetic patients, hospitalized with acute infectious diseases, in accordance with their increased GV level.
Most previous studies on GV and clinical outcomes focused on the settings of intensive care units, [14] [15] [16] [17] [18] [19] [20] [21] various patients admitted solely to medical wards 10 or on mixed surgical and medical patients. 11 Our study focused on a unique group, patients with acute infectious diseases who were admitted to medical wards. There are several ways to define GV. However, as the SD of glucose levels is highly correlated with the mean glucose levels, CV, calculated as the ratio of SD to mean glucose values, is considered an accurate and simple method to assess GV. 9, 11, 22, 23 There was no interaction between the diabetes status and GV with LOS, bacteremia rates and short term mortality. Other studies found an association between GV and LOS. A retrospective study, on 20 303 patients hospitalized in medical wards, showed that the mean LOS was longer with higher CV tertiles of glucose levels among diabetic and non-diabetic patients. 10 In another study on 935 medical and surgical patients, higher GV, presented by CV, was associated with longer LOS-a 9.7% increase in LOS with each 10 percentage point increment in CV of glucose levels (4.7-14.8%). 11 The fact that our study did not depict such association might be explained by the unique nature of the study cohort, patients with acute infection who were hospitalized for a short period and discharged upon their clinical improvement.
The study results suggest a significant association between high GV and increased risk of bacteremia. To the best of our knowledge, it is the first to explore this association. It might be explained by the decline in immunity secondary to the oxidative stress generated by glucose level variation, as was shown in previous studies. 24, 28 Analysis of the short term mortality reviled an increased in 30 and 90-days mortality in the entire cohort. Higher mortality rates in patients with increased GV might be explained by an increase in reactive oxygen species, 24, 25 impaired endothelial function by the fluctuations in glucose levels. 26, 27 Studies also
showed that GV had a more specific triggering effect on oxidative stress than did sustained chronic hyperglycemia. 24, 28 Analysis of the mortality at the end of follow-up (5 years) demonstrated lower survival while GV increases among patients with and without DM. These results are in line with the ones of a previous study, conducted in patients hospitalized at medical wards. 10 It is possible that GV is merely a marker of poor health status, as fluctuations in blood glucose levels might be in accordance with changes in renal, adrenal and liver dysfunction. Our study has several limitations. First, the retrospective nature of the study makes it vulnerable to collection bias and to potential inaccuracy in data collection. Second, it is a singlecenter study, limiting the generalizability of the results. Third, we can't state whether increased GV was a consequence or cause of the infections and their associated outcomes. Fourth, the small number of blood glucose level measurements per day. We based our findings on glucose levels that were measured in venous blood obtained daily by vein puncture because of the difficulties in retrieving data regarding glucose levels measured by bedside glucometers. Furthermore, bedside glucometers are not commonly used among patients without DM.
In conclusion, in patients, with and without DM, hospitalized in non-ICU setting with acute infections, increased GV is associated with increased risk of bacteremia as well as short and long-term mortality. Further studies are needed to clarify the effect of improved glucose levels control and reduction in GV on these outcomes.
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